Evotec is uniquely positioned to discover the next generation of drugs with higher efficacy and probability of success through our industrialized PanOmics approach towards molecular disease understanding and E.iPSC disease modeling platform. With this state-of-the-art toolbox, powered by AI and the expertise of our scientists, we are a driving force in drug discovery.

Explore Our Drug Discovery Toolbox

Target ID & Validation

Hit Identification

Structural Biology Services

Molecular Design & Medicinal Chemistry

In Vitro Biology

In Vivo Pharmacology

Biomarkers

Biophysics Services​

Protein Biochemistry

Cell Science Services

Safety Assessment

Early Formulation

Sample Management

ADME PK

Cell Painting

Modalities

Discover how our cutting-edge knowledge and specialized approach for each molecule type can help to shape the best strategy for bringing groundbreaking therapies to market.

Learn more

iPSC Drug Discovery

The industry-leading human iPSC-based drug screening platform which can model diseases in more than 15 cell types. Patient-derived cell-based assays and an enhanced molecular understanding of disease phenotypes are crucial to improving the accuracy of this disease modelling

Learn more

Molecular Patient Databases

A growing patient database in collaboration with high quality patient cohorts

Learn more

Contact Us

info@evotec.com

+49 40 560 81 0

Follow Us

Evotec Logo White Logo cyprotex white footer Logo justevotec biologics white footer

©2024, All right reserved.